PATENT CLAIM ANALYSIS

Application Number: 16123010
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["514", "04400R"]

Abstract:
This document provides methods and materials for treating cardiovascular and/or renal diseases. For example, AAV9 vectors designed to express natriuretic polypeptides, nucleic acid molecules encoding natriuretic polypeptides, methods for making AAV9 vectors, and methods for using such vectors or molecules to treat cardiovascular and/or renal diseases are provided.

Claim (Index 1):
An AAV9 vector comprising a nucleic acid sequence encoding a natriuretic polypeptide.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15436426', '15966288', '14370554', '12811306', '15625719']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.71837999809906
- 35 USC 102 Novelty (BERT): 0.606244330821818
- Combined Prediction Score: 0.7071664313713357
- Mean Citation Score: 484.2190559999999
- Max Citation Score: 636.1091
- Similarity Product: 431.7381846942604

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test